CIK 0001783036 · Non-accelerated filer<br>Emerging growth company
NewcelX Ltd.
Sign in to watch- Ticker
- NCEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41-41-618-80-00
- Business address
- THE CIRCLE 6, 8058, ZURICH, Switzerland
- Former names
- NLS Pharmaceutics Ltd.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 6-K Event Report of Foreign Issuer
- POS AM Other Post-effective Amendment for Registration Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 3 of 21 · 419 filings